RWE GENESYSResource HubPublications

Publications

We present a sample of our own publications, along with monthly highlighted publications from across the globe. Scroll down to discover more…

Big Data: transforming drug development and health policy decision making

Alemayehu, D. and Berger, M, (2016)

Big Data: transforming drug development and health policy decision making

Health Services and Outcomes Research Methodology, 16:92–102

View
Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value

Chen et al., (2016)

Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value

Journal of Personalized Medicine, 6, 20

View
Adding non-randomised studies to a Cochrane review brings complementary information for healthcare stakeholders: an augmented systematic review and meta-analysis

Arditi, C. et al., (2016)

Adding non-randomised studies to a Cochrane review brings complementary information for healthcare stakeholders: an augmented systematic review and meta-analysis

BMC Health Services Research, 16:598

View
UK Registry for Botulinum Toxin Type A use in cosmetic practice

Jandhyala, R., (2015)

UK Registry for Botulinum Toxin Type A use in cosmetic practice

Journal of Aesthetic Medicine, 1(1):1-5

View
Dermal fillers for facial rejuvenation: a review of clinical evidence

Jandhyala, R., (2015)

Dermal fillers for facial rejuvenation: a review of clinical evidence

Journal of Aesthetic Medicine, 1(1):6-13

View
Personal selling and its effectiveness in generating sales: an assessment of: ‘promotional’, ‘non–promotional’ personal selling and ‘non–‐personal’ selling as part of the Promotional Mix in the Pharmaceutical Industry

Jandhyala, R., (2015)

Personal selling and its effectiveness in generating sales: an assessment of: ‘promotional’, ‘non–promotional’ personal selling and ‘non–‐personal’ selling as part of the Promotional Mix in the Pharmaceutical Industry

MBA Thesis Article

View
Extracorporeal Photopheresis for Second-Line Treatment of Chronic Graft-versus-Host Disease: Results from a Health Technology Assessment in Italy

Waure De C., et al., (2015)

Extracorporeal Photopheresis for Second-Line Treatment of Chronic Graft-versus-Host Disease: Results from a Health Technology Assessment in Italy

Value in Health, 18:457-466

View
From Request to Delivery PhUse Conference 2015

Mewes, K. and Jandhyala, S., (2015)

From Request to Delivery PhUse Conference 2015

Paper DH07

View
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey

Longworth et al., (2014)

Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey

Health Technology Assessment, Feb;18(9):1-224

View
TECS CASE STUDY 002: Using telemedicine to reduce hospital admissions

NHS England, (2014)

TECS CASE STUDY 002: Using telemedicine to reduce hospital admissions

Airedale Hospital NHS Foundation Trust

View
Efficacy of Rapid-Onset Oral Fentanyl Formulations vs. Oral Morphine for Cancer-Related Breakthrough Pain: A Meta-Analysis of Comparative Trials

Jandhyala, R., (2013)

Efficacy of Rapid-Onset Oral Fentanyl Formulations vs. Oral Morphine for Cancer-Related Breakthrough Pain: A Meta-Analysis of Comparative Trials

Journal of Pain and Symptom Management, Oct;46(4):573-80

View
Improving consent procedures and evaluation of treatment success in cosmetic use of IncobotulinumtoxinA: An Assessment of the Treat-to-Goal Approach

Jandhyala, R., (2013)

Improving consent procedures and evaluation of treatment success in cosmetic use of IncobotulinumtoxinA: An Assessment of the Treat-to-Goal Approach

Journal of Drugs in Dermatology, Jan 1;12(1):72-8

View
Impact of Botulinum Toxin A on the quality of life of subjects following treatment of facial lines

Jandhyala, R., (2013)

Impact of Botulinum Toxin A on the quality of life of subjects following treatment of facial lines

Journal of Clinical Aesthetic Dermatology, Sep;6(9):41-5

View
Various formulations of oral transmucosal fentanyl for breakthrough cancer pain: an indirect mixed treatment comparison meta-analysis

Jandhyala, R., (2012)

Various formulations of oral transmucosal fentanyl for breakthrough cancer pain: an indirect mixed treatment comparison meta-analysis

BMJ Supportive Palliative Care Sep;6(9):41-5

View
Relative potency of incobotulinumtoxin A vs onabotulinumtoxin A, a meta-analysis of key evidence

Jandhyala, R., (2012)

Relative potency of incobotulinumtoxin A vs onabotulinumtoxin A, a meta-analysis of key evidence

Journal of Drugs in Dermatology, Jun;11(6):731-6

View
Effectiveness of Type A Botulinum Toxins for aesthetic indications and their relative economic impact

Jandhyala, R., (2012)

Effectiveness of Type A Botulinum Toxins for aesthetic indications and their relative economic impact

Journal of Plastic Reconstructive and Aesthetic Surgeons, Jun;65(6):720-31

View
Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview

Golder et al., (2011)

Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview

PLoS Medicine, May; 8(5)

View
Evaluating Translational Research: A Process Marker Model

Trochim, W. et al., (2011)

Evaluating Translational Research: A Process Marker Model

Clinical and Translational Science, Jun;4(3):153-62

View

REACH OUT TODAY

Arrange a call back...

Please leave this field empty.
curve
curve

Latest News

Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Read
CEO Colette Hamilton attends the UKs first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UKs Northern Tech Powerhouse

CEO Colette Hamilton attends the UKs first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UKs Northern Tech Powerhouse

Read
RWE Genesys sponsor conference session at 4th Annual Pharmacon Asia 2017,  19-22 September, One Farrer Hotel & Spa, Singapore

RWE Genesys sponsor conference session at 4th Annual Pharmacon Asia 2017, 19-22 September, One Farrer Hotel & Spa, Singapore

Read
Nanoparticles are changing the face of biomedical research

Nanoparticles are changing the face of biomedical research

Read